Stay updated on Nivolumab and Cyclophosphamide for R/R AML Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision label on the page changed from v3.6.2 to v3.6.3. This reflects a minor update to the study record's documentation and does not change the study content or participant-facing information.
    Difference
    0.1%
    Check dated 2026-07-03T21:51:39.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.0 to v3.6.2, reflecting a minor documentation update to the study page and its linked materials.
    Difference
    0.1%
    Check dated 2026-06-26T19:45:09.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now includes new guidance and join sections (How to Read a Study Record, Common Questions, How to Join a Study) and indicates that recruitment is closed ('No longer looking for participants'). Additionally, the 'Intervention / Treatment' heading was removed and the older revision note ('Revision: v3.5.5') was dropped, reflecting an updated and streamlined study page.
    Difference
    0.4%
    Check dated 2026-06-12T16:23:29.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Footer revision tag updated from Revision: v3.5.4 to Revision: v3.5.5, indicating a new site build version.
    Difference
    0.1%
    Check dated 2026-06-05T11:51:29.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.5.4 has been added, replacing the previous v3.5.3. This appears to be a minor update to the site framework or page rendering rather than a substantive change to the study details.
    Difference
    0.1%
    Check dated 2026-05-15T05:22:15.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page revision has been updated to v3.5.3, indicating a new build of the ClinicalTrials.gov page. No changes to the study details or eligibility information are evident.
    Difference
    0.1%
    Check dated 2026-04-30T18:28:20.000Z thumbnail image

Stay in the know with updates to Nivolumab and Cyclophosphamide for R/R AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page.